Neoantigen-specific CD8 T cell responses in the peripheral blood following PD-L1 blockade might predict therapy outcome in metastatic urothelial carcinoma | Nature Communications
SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8+ T cell activation in COVID-19 patients | Science Immunology
SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8+ T cell activation in COVID-19 patients | Science Immunology
Pepscan Presto B.v. - Lelystad 8243 RC (Lelystad), Zuidersluisweg 2 ,
Inhibition of triggering receptor expressed on myeloid cells‐1 impairs thrombin generation - Di Pillo - 2020 - Journal of Thrombosis and Haemostasis - Wiley Online Library
Microbiology Society on Twitter: "Congratulations to Samantha Ellis, who won the poster prize at Molecular Biology and Pathogenesis of Avian Viruses yesterday! #Avian18 https://t.co/jRYJml4gm1" / Twitter
Pepscan Presto B.v. - Lelystad 8243 RC (Lelystad), Zuidersluisweg 2 ,
Assays for oxytocin detection
A conserved immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies | Nature Communications
Pepscan...Enable life-improving breakthroughs by mastering peptides
Dutch Peptide Symposium2017 Eindhoven, June 8 Abstract book
Public Register of Sponsors For HSM Migrants Netherlands | PDF | Companies | Business
Pepscan Presto B.V. Lelystad - Oozo.nl
Pepscan Presto - Clinical Trials Arena
What are oxytocin assays measuring? Epitope mapping, metabolites, and comparisons of wildtype & knockout mouse urine - ScienceDirect
Mutational analysis of protein folding inside the ribosome exit tunnel - Farías‐Rico - 2017 - FEBS Letters - Wiley Online Library
Peptide selection from the four proteins through a combined in silico... | Download Scientific Diagram
Investigation of the marine compound spongistatin 1 links the inhibition of PKC translocation to nonmitotic effects of tubulin a
Pepscan Presto | Public Marketplace
Frontiers | Three doses of BNT162b2 COVID-19 mRNA vaccine establish long-lasting CD8+ T cell immunity in CLL and MDS patients
